238 related articles for article (PubMed ID: 21937590)
1. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
[TBL] [Abstract][Full Text] [Related]
2. A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.
Sromek M; Rymkiewicz G; Paziewska A; Szafron LM; Kulecka M; Zajdel M; Kulinczak M; Dabrowska M; Balabas A; Bystydzienski Z; Chechlinska M; Siwicki JK
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572608
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
Wang S; Xu Z; Zhang C; Yu R; Jiang J; Wang C; Qu C
Biomed Res Int; 2020; 2020():2102645. PubMed ID: 33083454
[TBL] [Abstract][Full Text] [Related]
4. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas.
Wu J; Al-Zahrani A; Beylerli O; Sufianov R; Talybov R; Meshcheryakova S; Sufianova G; Gareev I; Sufianov A
Front Oncol; 2022; 12():898537. PubMed ID: 35646622
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study.
Vera S; Sinning M; Vergara M; Lemus D; Rosas C
J Neurooncol; 2019 Nov; 145(2):233-239. PubMed ID: 31624989
[TBL] [Abstract][Full Text] [Related]
8. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
[TBL] [Abstract][Full Text] [Related]
9. Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment.
Mafi A; Rahmati A; Babaei Aghdam Z; Salami R; Salami M; Vakili O; Aghadavod E
Cell Mol Biol Lett; 2022 Aug; 27(1):65. PubMed ID: 35922753
[TBL] [Abstract][Full Text] [Related]
10. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
11. Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease.
Wang G; Wen Y; Chen S; Zhang G; Li M; Zhang S; Qi S; Feng W
CNS Neurosci Ther; 2021 Aug; 27(8):908-918. PubMed ID: 33942536
[TBL] [Abstract][Full Text] [Related]
12. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma.
Si PP; Zhou XH; Qu ZZ
J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.
Nikolova E; Georgiev C; Laleva L; Milev M; Spiriev T; Stoyanov S; Taseva-Mineva T; Mitev V; Todorova A
Mol Genet Genomics; 2022 Mar; 297(2):357-371. PubMed ID: 35064290
[TBL] [Abstract][Full Text] [Related]
14. Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.
Muñoz-San Martín M; Reverter G; Robles-Cedeño R; Buxò M; Ortega FJ; Gómez I; Tomàs-Roig J; Celarain N; Villar LM; Perkal H; Fernández-Real JM; Quintana E; Ramió-Torrentà L
J Neuroinflammation; 2019 Nov; 16(1):220. PubMed ID: 31727077
[TBL] [Abstract][Full Text] [Related]
15. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
16. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
[TBL] [Abstract][Full Text] [Related]
18. A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease.
Wang G; Wen Y; Faleti OD; Zhao Q; Liu J; Zhang G; Li M; Qi S; Feng W; Lyu X
Front Neurosci; 2020; 14():548278. PubMed ID: 33100957
[TBL] [Abstract][Full Text] [Related]
19. Expression of microRNAs in plasma and in extracellular vesicles derived from plasma for dogs with glioma and dogs with other brain diseases.
Narita M; Nishida H; Asahina R; Nakata K; Yano H; Dickinson PJ; Tanaka T; Akiyoshi H; Maeda S; Kamishina H
Am J Vet Res; 2020 Apr; 81(4):355-360. PubMed ID: 32228257
[TBL] [Abstract][Full Text] [Related]
20. Protein biomarker identification in the CSF of patients with CNS lymphoma.
Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
